Eunethta.eu

Written by Nicole Scholz, © jianghaistudio / Fotolia Health Technology Assessment (HTA) is a research-based tool to support decision-making in healthcare. HTA assesses the added value of new health technologies – medicines, medical devices and diagnostic...

European Ministers of Health also adopted conclusions on innovation for the benefit of patients at a Council meeting on 1 December 2014. Ministers are calling on national governments and the European Commission to cooperate more closely on the 'life...

Brexit and the EU’s Response On January 17, in a speech in Lancaster House to the British diplomatic corps, Prime Minister Theresa May presented her “plan for Britain”, which includes 12 “priorities” the UK government will defend in the Brexit negotiations...

OrphaNews : the newsletter of the Rare Disease Community Editorial RD-ACTION: the new European Rare Disease Joint Action RD-ACTION, the new Joint Action consisting of the member states of the European Union for rare diseases, was launched on 17 September...

New EUnetHTA joint action, co-financed by the EC and participating bodies from nearly all EU Member States,  is due to start in early 2016. One of the work packages will be dedicated to evidence generation, dealing with the question of early dialogue...